feedback

Course Director

Claus Bachert, MD, PhD

Ghent University Hospital
Ghent, Belgium

Accredited by

Purdue University College of Pharmacy

View Activity Materials

Activity Details

Credit Types:CME
Credit Amount:0.5 Credits
Release Date:2020-Jun-29
Expiration Date:2021-Jun-28
Estimated Time for Completion:30 minutes
Registration Required:No
Cost:Free of Charge

Support

This activity is supported by an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.

Activity Description and Educational Objectives

In this activity, an expert in rhinology discusses strategies to improve the diagnosis and management of chronic rhinosinusitis with nasal polyps, as well as how to include emerging therapies in the care pathway.

Upon completion of this activity, participants should be better able to:
  • Discuss the pathophysiology and etiology of chronic rhinosinusitis with nasal polyps (CRSwNP)
  • Identify risk factors, signs, and symptoms of CRSwNP to improve recognition and diagnosis
  • Describe the current and emerging pharmacologic treatment options for CRSwNP, as well as considerations for matching patients to treatment

Target Audience

This activity has been designed to meet the educational needs of allergists, pulmonologists, respirologists, ENTs/otorhinolaryngologists, surgeons, and other clinicians involved in the treatment of chronic rhinosinusitis with nasal polyps.

Faculty Disclosure Statement / Conflict of Interest Policy

All faculty, staff, and reviewers involved in the planning, review or presentation of continuing education activities provided by Purdue University College of Pharmacy are required to disclose to the audience any relevant commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. Any identified relevant conflicts of interest were resolved for fair balance and scientific objectivity of studies utilized in this activity.

All additional planning committee members, staff, and reviewers of Purdue University College of Pharmacy and Answers in CME have no relationships to disclose.

Course Director and Faculty

Claus Bachert, MD, PhD
Head Upper Airways Research Laboratory (URL)
Chief of Clinics ENT-Department
Ghent University Hospital
Ghent, Belgium

Claus Bachert, MD, PhD, has a financial interest/relationship or affiliation in the form of:
Consultant for AstraZeneca; GlaxoSmithKline plc.; Novartis AG; and Sanofi.
Speakers Bureau participant with AstraZeneca; GlaxoSmithKline plc.; Novartis AG; and Sanofi.

Answers in CME Medical Director

Sonia Schursky, MD, has no financial interests/relationships or affiliations in relation to this activity.

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use in certain jurisdictions. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our materials. No responsibility is taken for errors or omissions in our materials.

Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Purdue University College of Pharmacy and Answers in CME. Purdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the ACCME to provide continuing medical education for physicians.

The Purdue University College of Pharmacy designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The European Union of Medical Specialists (UEMS)-European Accreditation Council for Continuing Medical Education (EACCME) has an agreement of mutual recognition of continuing medical education (CME) credit with the American Medical Association (AMA). European physicians interested in converting AMA PRA Category 1 Credit™ into European CME credit (ECMEC) should contact the UEMS (www.uems.eu).

Purdue University College of Pharmacy
This CME activity is jointly provided by Purdue University College of Pharmacy and Answers in CME.

Requirements for Successful Completion

To receive credit, participants must complete the activity, the post-test, and the evaluation form prior to the expiration date noted below. There are no pre-requisites and there is no fee to participate in this activity or to receive credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form. Consult your professional licensing board for information about your eligibility to claim credit for participation in this educational activity. A minimum performance level of 80% is needed.

Media: Enduring Material
Release and Expiration Dates: June 29, 2020 - June 28, 2021
Time to Complete: 30 minutes

Disclaimer

The participants of this educational activity have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.

The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of Answers in CME or any of its supporters.

About This Answers in CME Activity

Answers in CME and Purdue University College of Pharmacy, are responsible for the selection of this activity's topics, the preparation of educational content, and the distribution of this activity. The preparation of Answers in CME activities is supported by written agreements that clearly stipulate and enforce the independence of Answers in CME, Purdue University College of Pharmacy, and the faculty presenters.

The faculty may discuss unapproved products or uses of these products in certain jurisdictions. Faculty presenters have been advised to disclose any reference to an unlabeled or unapproved use. No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our activities. No responsibility is taken for errors or omissions.

For approved prescribing information, please consult the manufacturer's product monograph.

© 2018-2020, Answers in CME

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.